Search results
Brilinta (Ticagrelor) vs. Plavix (Clopidogrel): Which Is Better?
Verywell Health via Yahoo News· 6 months agoBrilinta (ticagrelor) and Plavix (clopidogrel) are blood-thinning medications, also called blood...
12 Commonly Prescribed Blood Thinners
Verywell Health via Yahoo News· 2 months agoMedically reviewed by Alex Yampolsky, PharmD Blood thinners are a type of medication that prevents blood clots from forming in the body. There are two...
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoCytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript March 14, 2024 Cytosorbents...
AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN stock has risen 5.1% in the past year compared with an increase of 2% for the...
AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN fourth-quarter 2022 core earnings of 69 cents per American depositary share (ADS)...
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
Zacks via Yahoo Finance· 1 year agoAstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS)...
Q2 2023 Cytosorbents Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 months agoParticipants Christian Steiner; EVP of Sales & Marketing; Cytosorbents Corporation Christopher Cramer; VP of Business Development; Cytosorbents Corporation Efthymios N. Deliargyris; Chief Medical ...
Pharma Stock Roundup: Q3 Earnings of BAYRY, AZN, EU Nod for AZN, SNY RSV Vaccine
Zacks via Yahoo Finance· 2 years agoThis week, AstraZeneca AZN and Sanofi’s SNY RSV vaccine, nirsevimab and Sanofi and GSK’s GSK...
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 1 month agoWhile the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business...
PhaseBio Might Have To Return Global Rights To Its Lead Program
Benzinga via Yahoo Finance· 2 years agoPhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) received a notice that its partner SFJ Pharmaceuticals...